The Voice of the Voiceless

We are here to protect you from negligent companies and help you hold them accountable for the injuries you suffered.

877.806.2629

Abilify MDL discovery phase keeps going forward

As new Abilify lawsuits keep being filed every day, the discovery phase of the Multidistrict Litigation No. 2734 keeps moving forward. Judge James J. DeLuca is currently overseeing over the centralized cases, and just issued a lengthy order to set forth a list of...

Plaintiff From Virginia Files New Hernia Mesh Lawsuit

A plaintiff from Virginia, Scott H., just filed a new hernia mesh lawsuit against Ethicon Inc. after suffering serious complications and injuries. The man sued the manufacturer after the Physiomesh device he was implanted with caused him serious side effects including...

J&J seeks to expand Invokana indications despite its dangers

Despite its numerous risks and dangers, Johnson & Johnson decided to move forward towards expanding the market for the antidiabetes drug Invokana. The controversial medication is, in fact, associated with many serious side effects such as kidney failure, increased...

J&J Settles Transvaginal Mesh Lawsuit — Woman Receives $57 Million

Ella Ebaugh, 51, received a $57 million settlement after filing a Transvaginal Mesh lawsuit against Ethicon and Johnson & Johnson. The plaintiff from Pennsylvania sued the two giant corporations after being implanted with the device that caused her to suffer from...

Court reviews current status of the Levaquin (Fluoroquinolones) MDL

The United States District Court for the District of Minnesota issued a conference to oversee the current status of the Fluoroquinolones Antibiotics MDL (Levaquin, Avelox and Cipro). Centralized by the U.S. Judicial Panel on Multidistrict Litigation (JMPL) in August...

New study found Abilify’s adverse reactions outweigh its benefits

A new study found that the antidepressant effects of Abilify (aripiprazole) are so minimal that its risks significantly outweigh the alleged benefits. The medication manufactured by Bristol-Myers Squibb is one of the most controversial ones actually sold in the U.S....

Bayer wins Xarelto Bellwether trial for the third time

For the third time in a row, Bayer and Janssen Pharmaceutical won the Xarelto bellwether trial scheduled for August 2017. A federal jury in the U.S. District Court, Southern District of Mississippi, handed a favorable verdict to the manufacturers against a plaintiff...